Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients

NCT07159620 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Adult T-cell Leukemia/Lymphoma

Interventions

DRUG: VEN (Venetoclax)
DRUG: Azacitidine (AZA)
DRUG: Chidamide
DRUG: vindesine
DRUG: Dexamethasone

Sponsor

The First Affiliated Hospital of Soochow University